Amine Benmoussa

Amine has over 15 years of experience in HealthTech VC investing both in North America and in Europe.

Prior to joining Karista, Amine worked as an investor with the BDC Healthcare Fund in Canada where he led or co-led investments in early to mid-stage healthcare companies, and served on several boards, including those of Circle Cardiovascular Imaging (Acquired by ThomaBravo), Clearwater Clinical (acquired by Sivantos), Clementia Pharmaceuticals (IPO and later acquired by IPSEN), Milestone Pharmaceuticals (IPO) and Swift Medical.

Amine joined Karista as VC Partner, focusing on HealthTech investments. He currently serves on the board of directors of RebrAIn. He is also actively engaged in the firm’s fundraising activities.

Amine holds a Bachelor of Computer Science from Concordia University and an MBA from HEC Montreal. He has also completed executive training in PE/VC at the Harvard Business School and in Corporate Governance at the Rotman School of Management.